Evidence map›Paper›PMID 24470956›Full record

ReviewInfectious disease reports2013

Emergence of Carbapenemaseproducing Klebsiella Pneumoniae of Sequence type 258 in Michigan, USA.

Ruchika Jain, Seth T Walk, David M Aronoff, Vincent B Young, Duane W Newton, Carol E Chenoweth, Laraine L Washer

Abstract readReview
In one paragraph

Review in Infectious disease reports, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Carbapenemase Production and Epidemiological Characteristics of Carbapenem-ResistantFrontiers in cellular and infection microbiology · 2021
    Article
  3. An Outbreak of Carbapenem-ResistantFrontiers in cellular and infection microbiology · 2021
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ruchika JainDivision of Infectious Diseases, Department of Internal Medicine, University of Michigan Health System , Ann Arbor, MI.
Seth T WalkDivision of Infectious Diseases, Department of Internal Medicine, University of Michigan Health System , Ann Arbor, MI.
David M AronoffDivision of Infectious Diseases, Department of Internal Medicine, University of Michigan Health System , Ann Arbor, MI ; Department of Microbiology and Immunology, University of Michigan Medical School , Ann Arbor, MI.
Vincent B YoungDivision of Infectious Diseases, Department of Internal Medicine, University of Michigan Health System , Ann Arbor, MI ; Department of Microbiology and Immunology, University of Michigan Medical School , Ann Arbor, MI.
Duane W NewtonDepartment of Pathology, University of Michigan Health System , Ann Arbor, MI.
Carol E ChenowethDivision of Infectious Diseases, Department of Internal Medicine, University of Michigan Health System , Ann Arbor, MI ; Department of Infection Control and Epidemiology, University of Michigan Health System , Ann Arbor, MI, USA.
Laraine L WasherDivision of Infectious Diseases, Department of Internal Medicine, University of Michigan Health System , Ann Arbor, MI ; Department of Infection Control and Epidemiology, University of Michigan Health System , Ann Arbor, MI, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The prevalence of carbapenemase-producing Enterobacteriaceae (CPE) in our hospital increased beginning in 2009. We aimed to study the clinical and molecular epidemiology of these emerging isolates. We performed a retrospective review of all adult patients with clinical cultures confirmed as CPE by positive modified Hodge test from 5/2009- 5/2010 at the University of Michigan Health System (UMHS). Clinical information was obtained from electronic medical records. Available CPE isolates were analyzed by polymerase chain reaction (PCR) and sequencing of the 16S rRNA encoding gene and bla KPC locus. Multilocus sequence typing (MLST) was used to characterize Klebsiella pneumoniae isolates. Twenty six unique CPE isolates were obtained from 25 adult patients. The majority were Klebsiella pneumoniae (n=17). Other isolates included K. oxytoca (n=3), Citrobacter freundii (n=2), Enterobacter cloacae (n=2), Enterobacter aerogenes (n=1) and Escherichia coli (n=1). Molecular characterization of 19 available CPE isolates showed that 13 (68%) carried the KPC-3 allele and 6 (32%) carried the KPC-2 allele. Among 14 available K. pneumoniae strains, 12 (86%) carried the KPC-3 allele and belonged to a common lineage, sequence type (ST) 258. The other 2 (14%) K. pneumoniae isolates carried the KPC-2 allele and belonged to two unique STs. Among these ST 258 strains, 67% were isolated from patients with prior exposures to health care settings outside of our institution. In contrast, all CPE isolates carrying the KPC-2 allele and all non ST 258 CPE isolates had acquisition attributable to our hospital. Molecular epidemiology of carbapenemase producing K. pneumoniae suggests that KPC-3 producing K. pneumoniae isolates of a common lineage, sequence type (ST 258), are emerging in our hospital. While ST 258 is a dominant sequence type throughout the United States, this study is the first to report its presence in Michigan.

Indexed as

carbapenemaseEnterobacteriaceaeKlebsiella pneumoniaeST 258

Identifiers

PMID24470956
PMCPMC3892616

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.